Physiopathology of Behavioral Addictions and Biomarkers (MiRACle)
Physiopathology of Behavioral Addictions and Biomarkers: microRNAs Implication - MiRACle : a Pilot Study.
The goal of this observational study is to evaluate the expression of miR-10a-5p in the blood in patients with sexual addiction or food addiction. The main question it aims to answer is : To determine whether adults patients with SA or FA exhibit a distinct blood miR-10a-5p expression profile compared with matched healthy controls.
For all participants, one blood sample will be collected.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Pr Caroline Victorri-Vigneau
- Telefonnummer: 02.40.84.76.20
- E-mail: marie.bronnec@chu-nantes.fr
Studiesteder
-
-
-
Nantes, Frankrig
- Nantes University Hospital
-
Kontakt:
- Gaëlle CHALLET
- Telefonnummer: 02.40.84.76.20
- E-mail: gaelle.bouju@chu-nantes.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Patients with food or sexual addiction, compared with age- and sex-matched healthy controls with no current addictive disorder.
Beskrivelse
Inclusion criteria
For patients with FA:
- Male and females ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of FA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with FA:
- Male and females ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For patients with SA:
- Male ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of SA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with SA:
- Male ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
Exclusion Criteria :
For patients with FA:
- Presence of a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For patients with SA:
- Presence of a current diagnosis of FA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For healthy controls:
- Without a current diagnosis of FA
- Without a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: CASE_CONTROL
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Patients with addiction
Patients with food addiction (FA) or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
|
Healthy controls
Healthy controls matched on sex and age to patients with food addiction or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood miR-10a-5p expression
Tidsramme: 3 months
|
The concentration of each miR-enriched fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood additional circulating miRs expression
Tidsramme: 3 months
|
The concentration of circulating miRs fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and age |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and sex |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and duration of addiction |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and severity of addiction |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and tobacco-use |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and psychiatric disorders |
3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Seksuelle dysfunktioner, psykologiske
- Adfærd, vanedannende
- Kompulsiv adfærd
- Impulsiv adfærd
- Ernærings- og spiseforstyrrelser
- Seksuelle og kønslidelser
- Opførsel
- Madafhængighed
- Kompulsiv seksuel adfærdsforstyrrelse
- Undersøgelsesteknikker
- Håndtering af eksemplar
- Kliniske laboratorieteknikker
- Diagnostiske teknikker og procedurer
- Diagnose
- Punkteringer
- Kirurgiske procedurer, operative
- Blodprøveopsamling
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- RC26_0091
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .